Tag: M.W:100-200

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 214045-84-8, name is 6-Fluoro-3,4-dihydroisoquinolin-1(2H)-one, introducing its new discovery. 214045-84-8

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.214045-84-8, you can also check out more blogs about214045-84-8

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels.In a patent£¬Which mentioned a new discovery about 19493-44-8, molcular formula is C9H6ClN, introducing its new discovery. , 19493-44-8

Iron catalyzed cross coupling reactions of aromatic compounds

A process for the production of compounds Ar?R1 by means of a cross-coupling reaction of an organometallic reagent R1?M with an aromatic or heteroaromatic substrate Ar?X catalyzed by one or several iron salts or iron complexes as catalysts or pre-catalysts, present homogeneously or heterogeneously in the reaction mixture. This new invention exhibits substantial advantages over established cross coupling methodology using palladium- or nickel complexes as the catalysts. Most notable aspects are the fact that (i) expensive and/or toxic nobel metal catalysts are replaced by cheap, stable, commercially available and toxicologically benign iron salts or iron complexes as the catalysts or pre-catalysts, (ii) commercially attractive aryl chlorides as well as various aryl sulfonates can be used as starting materials, (iii) the reaction can be performed under ?ligand-free? conditons, and (iv) the reaction times are usually very short.

Because enzymes can increase reaction rates by enormous factors and tend to be very specific, 19493-44-8, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 19493-44-8

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

1125-80-0, Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments.Introducing a new discovery about 1125-80-0, Name is 3-Methylisoquinoline

Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors

The purpose of this study was to determine the cytochrome P450 1A2 (CYP1A2) inhibition potencies of structurally diverse compounds to create a comprehensive three-dimensional quantitative structure-activity relationship (3D-QSAR) model of CYP1A2 inhibitors and to use this model to predict the inhibition potencies of an external set of compounds. Fifty-two compounds including naphthalene, lactone and quinoline derivatives were assayed in a 96-well plate format for CYP1A2 inhibition activity using 7-ethoxyresorufin O-dealkylation as the probe reaction. The IC50 values of the tested compounds varied from 2.3 muM to over 40 000 muM. On the basis of this data set, a comparative molecular field analysis (CoMFA) and GRID/ GOLPE models were created that yielded novel structural information about the interaction between inhibitory molecules and the CYP1A2 active site. The created CoMFA model was able to accurately predict inhibitory potencies of several structurally unrelated compounds, including selective inhibitors of other cytochrome P450 forms.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 1125-80-0, help many people in the next few years.1125-80-0

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

22246-12-4, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 22246-12-4, molcular formula is C10H11NO2, introducing its new discovery.

INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS

The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring C, X1, X2, L1, R1, R2, R3, R4, R5, R6, R7, m and n are as defined herein, which are useful as MAP4K1 inhibitors, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by MAP4K1.

Because enzymes can increase reaction rates by enormous factors and tend to be very specific, 22246-12-4, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 22246-12-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

22246-12-4, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 22246-12-4, molcular formula is C10H11NO2, introducing its new discovery.

Vitronectin receptor antagonists

Compounds of formula (I) are disclosed, wherein: A is a fibrinogen antagonist template; W is a linking moiety of the form –(CHRg)a –U–(CHRg)b –V–; Q1, Q2, Q3 and Q4 are independently N or C–Ry, provided that no more than one Q1, Q2, Q3 and Q4 is N; R’ is H or C1-6 alkyl, C3-7 cycloalkyl-C0-6 -alkyl or Ar–C0-6 alkyl; Rg is H or C1-6 alkyl, Het-C0-6 alkyl, C3-7 cycloalkyl-C0-6 alkyl or Ar–C0-6 alkyl; Rk is Rg, –C(O)Rg or –C(O)ORg Ri is H, C1-6 alkyl, Het-C0-6 alkyl, C3-7 cycloalkyl-C0-6 alkyl, Ar–C0-6 alkyl, Het-C0-6 alkyl–U’–C1-6 alkyl, C3-7 cycloalkyl-C0-6 alkyl–U’–C1-6 alkyl or Ar–C0-6 alkyl–U’–C1-6 alkyl; Ry is H, halo, –ORg, –SRg, –CN, –NRg Rk, –NO2, –CF3, CF3 S(O)r, –CO2 Rg, –CORg or –CONRg2, or C1-6 alkyl optionally substituted by halo, –ORg, –SRg, –CN, –NR8 R”, –NO2, –CF3, R’S(O)3 –, –CO2 Rg, –CORg or –CONRg2 ; U and V are absent or CO, CRg2, C(=CRg2), S(O)c, O, NRg, CRg ORg, CRg (ORk)CRg2, CRg7 CRg (ORk), C(O)CRg2, CRg2 C(O), CONRi, NRi CO, OC(O), C(O)O, OC(S), C(S)NRg, NR8 C(S), S(O2 NRg, NRg S(O)2 N=N, NRg NRg, NRg CRg2, NRg CRg2, CRg2 O, OCRg2, CRg =CRg, C?C, Ar or Het; a is 0, 1 or 2; c is 0, 1 or 2; r is 0, 1 or 2; and u is 0 or 1; or pharmaceutically acceptable salts thereof, which are vitronectin receptor antagonists useful in the treatment of osteoporosis. STR1

Because enzymes can increase reaction rates by enormous factors and tend to be very specific, 22246-12-4, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 22246-12-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

22246-12-4, Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments.Introducing a new discovery about 22246-12-4, Name is 6-Methoxy-3,4-dihydroisoquinolin-1(2H)-one

Facile synthesis of 5-To 7-membered benzolactam compounds via strongly facilitated electrophilic aromtic substitution reaction

We employed our system to activate aromatic ring-Tethered carbamate compounds with trifluoromethanesulfonic acid to obtain benzolactams with 5-To 7-membered rings, and examined the substrate scope and limitations of this activation method. In 5-membered ring formation, a halogen group on the aromatic ring did not greatly affect the reaction yield, but other electron-donating groups inhibited the cyclization reaction, and various side-reactions occurred. In 7-membered ring formation, eletron-donating groups on aromatic ring promoted the cyclization reaction, but cyclization of electron-deficient aromatic rings did not proceed well. The 6-membered ring formation reaction showed the greatest substrate generality.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 22246-12-4, help many people in the next few years.22246-12-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 347146-33-2, molecular formula is C9H7ClN2, introducing its new discovery. 347146-33-2

Integrin expression inhibitors

The present invention provides an integrin expression inhibitor, and an agent for treating arterial sclerosis, psoriasis, cancer, retinal angiogenesis, diabetic retinopathy or inflammatory diseases, an anticoagulant, or a cancer metastasis suppressor on the basis of an integrin inhibitory action. Namely, it provides an integrin expression inhibitor comprising, as an active ingredient, a sulfonamide compound represented by the following formula (I), a pharmacologically acceptable salt thereof or a hydrate of them. 1In the formula, B means a C6-C10 aryl ring or 6- to 10-membered heteroaryl ring which may have a substituent and in which a part of the ring may be saturated; K means a single bond, ?CH=CH? or ?(CR4bR5b)mb? (wherein R4b and R5b are the same as or different from each other and each means hydrogen atom or a C1-C4 alkyl group; and mb means an integer of 1 or 2); R1 means hydrogen atom or a C1-C6 alkyl group; Z means a single bond or ?CO?NH?; and R means a C6-C10 aryl ring or 6- to 10-membered heteroaryl ring which may have a substituent and in which a part of the ring may be saturated, respectively.

347146-33-2, Interested yet? Read on for other articles about 347146-33-2!

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

22245-98-3, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 22245-98-3, molcular formula is C9H9NO2, introducing its new discovery.

1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS

The present invention relates to compounds of formula (I) in which n, R1, R2, R3, R4and R5 are as defined in the claims; capable of being both potent antagonists and degraders of estrogen receptors. Also described is a process for the preparation of compounds of the invention, and the invention further provides pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with aberrant estrogen receptor activity.

Because enzymes can increase reaction rates by enormous factors and tend to be very specific, 22245-98-3, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 22245-98-3

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Chemistry can be defined as the study of matter and the changes it undergoes. 19493-44-8. You¡¯ll sometimes hear it called the central science because it is the connection between physics and all the other sciences, starting with biology.19493-44-8, Name is 1-Chloroisoquinoline, molecular formula is C9H6ClN, introducing its new discovery.

Saturated red iridium(iii) complexes containing a unique four-membered Ir-S-C-N backbone: Mild synthesis and application in OLEDs

A series of new iridium(iii) cyclometalated complexes (4tfmpiq)2Ir(tiptha), (4tfmpiq)2Ir(phdiptha), (4tfmpiq)2Ir(fphdiptha) and (4tfmpiq)2Ir(ipdptha) (4tfmpiq = 4-(4-(trifluoromethyl)phenyl)isoquinoline, tiptha = 1,1,3-triisopropylthiourea, phdiptha = 1,1-diisopropyl-3-phenylthiourea, fphdiptha = 3-(4-fluorophenyl)-1,1-diisopropylthiourea, ipdptha = 3-isopropyl-1,1-diphenylthiourea) containing a unique four-membered ring Ir-S-C-N backbone were facilely synthesized under mild conditions. By introducing different substituents such as isopropyl, phenyl, 4-fluorophenyl, diisopropylamine and diphenylamine on the thiourea ancillary ligands, not only the S-C-N ligands can be extensively derived, but also the emission colors (lambdapeak = 627-636 nm) and photoluminescence quantum efficiencies (PhiP = 38.0-42.0%) can be regulated. Employing these complexes as emitters, the organic light emitting diodes (OLEDs) exhibited good performances with a maximum external quantum efficiency (EQEmax) of 13.1% for saturated red emission with CIE coordinates of (0.68, 0.32). These results demonstrate the great potential of the S-C-N ancillary ligands for developing new Ir(iii) complexes towards OLED applications.

19493-44-8, Interested yet? Read on for other articles about 19493-44-8!

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 93117-08-9, molecular formula is C9H8N2O, introducing its new discovery. 93117-08-9

TANKYRASE INHIBITORS

The present invention relates to a compound of formula I wherein X is C(R6) or N, Y is C or N, and ring A, ring B, R1 and R2 have the meanings defined herein, provided that when ring B is carbocyclic, X is C(R6); or a pharmaceutically acceptable salt or solvate thereof. The compounds are tankyrase-1 and tankyrase-2 inhibitors and are useful in the treatment of a number of conditions, including cancer.

93117-08-9, Interested yet? Read on for other articles about 93117-08-9!

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem